Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 30 Similar Profiles
Therapeutics Medicine & Life Sciences
Head and Neck Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Survival Medicine & Life Sciences
Oropharyngeal Neoplasms Medicine & Life Sciences
Squamous Cell Carcinoma Medicine & Life Sciences
Laryngeal Neoplasms Medicine & Life Sciences
Chemoradiotherapy Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 2000 2025

Research Output 1994 2017

  • 5258 Citations
  • 34 Scopus h-Index
  • 122 Article
  • 18 Review article
  • 4 Comment/debate
  • 1 Letter

ACR appropriateness criteria® nasal cavity and paranasal sinus cancers

Siddiqui, F., Smith, R. V., Yom, S. S., Beitler, J. J., Busse, P. M., Cooper, J. S., Hanna, E. Y., Jones, C. U., Koyfman, S. A., Quon, H., Ridge, J. A., Saba, N. F., Worden, F., Yao, M., Salama, J. K. & Expert Panel on Radiation Oncology – Head and Neck Cancer Mar 1 2017 In : Head and Neck. 39, 3, p. 407-418 12 p.

Research output: Research - peer-reviewArticle

Paranasal Sinus Neoplasms
Paranasal Sinuses
Nasal Cavity
Radiology
Guidelines

Buparlisib—and the continued quest for the ideal cure

Worden, F. P. Mar 1 2017 In : The Lancet Oncology. 18, 3, p. 273-274 2 p.

Research output: Research - peer-reviewComment/debate

Dusquetide: Reduction in oral mucositis associated with enduring ancillary benefits in tumor resolution and decreased mortality in head and neck cancer patients

Kudrimoti, M., Curtis, A., Azawi, S., Worden, F., Katz, S., Adkins, D., Bonomi, M., Scott, Z., Elder, J., Sonis, S. T., Straube, R. & Donini, O. Sep 1 2017 In : Biotechnology Reports. 15, p. 24-26 3 p.

Research output: Research - peer-reviewArticle

Stomatitis
Head and Neck Neoplasms
Mortality
Neoplasms
Therapeutics
2 Citations
Squamous Cell Carcinoma
Biomarkers
Recurrence
Antibodies
Serum
1 Citations

Effect of age on the efficacy and safety of lenvatinib in radioiodine-refractory differentiated thyroid cancer in the phase III select trial

Brose, M. S., Worden, F. P., Newbold, K. L., Guo, M. & Hurria, A. Aug 10 2017 In : Journal of Clinical Oncology. 35, 23, p. 2692-2699 8 p.

Research output: Research - peer-reviewArticle

Thyroid Neoplasms
Safety
lenvatinib
Disease-Free Survival
Placebos